A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus-Like Particle Vaccine

Condition:   Chikungunya Virus Intervention:   Biological: CHIKV VLP, adjuvanted Sponsor:   Emergent BioSolutions Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials